
During a live event, Pedro Barata, MD, MSc, and participating oncologists discussed how efficacy, tolerability, and clinical evidence inform subsequent-line treatment selection for metastatic clear cell renal cell carcinoma.
Perspective on the Treatment of Advanced Renal Cell Cancer
A Japanese-American Male With Recurrent RCC
November 2015
September 2017
July 2018